CFO interim
MapLight Therapeutics, Inc. names Jonathan Gillis interim CFO
MapLight Therapeutics, Inc. reported in a Form 8-K filed June 18, 2026 that Jonathan Gillis was named interim Chief Financial Officer and interim principal financial officer, effective June 18, 2026.
In the filing's words
In connection with the separation of Mr. Setia, the board of directors of the Company appointed Jonathan Gillis, the Company’s Chief Administrative and Accounting Officer, as the Company’s interim Chief Financial Officer and interim principal financial officer, effective June 18, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | MapLight Therapeutics, Inc. (MPLT) |
|---|---|
| Event | Interim |
| Incoming | Jonathan Gillis |
| Outgoing | Vishwas Setia |
| Title in the filing | interim Chief Financial Officer and interim principal financial officer |
| Effective | June 18, 2026 |
| 8-K filed | June 18, 2026 |
| Internal promotion | Not established by the source |
| SEC CIK | 0001770069 |
MapLight Therapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed June 18, 2026. The filing's own words are quoted above.
Other records naming Vishwas Setia
1The outgoing officer on this record, matched by name. Career line.
2026-03-26 · 10-K signature
Vishwas Setia signed MapLight Therapeutics, Inc.'s annual report as Chief Financial Officer (Principal Financial Officer)
Same industry, June 2026
8Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
5 months ago· 2026-06-18TransitionPTPI
Petros Pharmaceuticals, Inc. CFO transition: Robert Weinstein to succeed Mitchell Arnold
5 months ago· 2026-06-15AppointmentSNSE
Sensei Biotherapeutics, Inc. appoints Brian Stephenson as CFO
5 months ago· 2026-06-12AppointmentOCUL
Ocular Therapeutix, Inc. appoints Jason Robins as CFO
5 months ago· 2026-06-04AppointmentBYSI
BeyondSpring Inc. appoints Na Li as CFO
5 months ago· 2026-06-03InterimCVKD
Cadrenal Therapeutics, Inc. names Quang X. Pham interim CFO
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Jonathan Gillis? Send a correction with the primary source.